4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-16-137607
SVP & Chief Scientific Officer sold 1,336 shares at $17.56 ($23,460)
From the SEC's structured data for this filing
Trades in this filing
Doberstein Stephen K · SVP & Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-08-16 | Sale : show line 1 in the form | −1,336 | $17.56 | $23,460 | 18,935 | D |
| Open-market sales · 1,336 sh · avg $17.56 · $23,460 | ||||||
Loading xslF345X03/doc4.xml…